RHY 4.76% 6.0¢ rhythm biosciences limited

Lack of communication, page-3

  1. 1,245 Posts.
    lightbulb Created with Sketch. 120
    We've enough capital as far as I know, and no clinical test means no more usage of our funds, from available funds perspective I'm not too worried, but management going quiet and not really releasing any news to shareholders means something fishy going on. however, RHY always been this way - less news / announcements. very frustrating to shareholders.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.